Médiastinite à Aspergillus après lobectomie post immunothérapie pour un cancer du poumon oligométastatique
- 1 May 2022
- journal article
- research article
- Published by Elsevier BV in Revue des Maladies Respiratoires
- Vol. 39 (5), 498-501
- https://doi.org/10.1016/j.rmr.2022.04.002
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Fungal Infections Associated With the Use of Novel Immunotherapeutic AgentsCurrent Clinical Microbiology Reports, 2020
- Resistance mechanism and proteins in Aspergillus species against antifungal agentsMycology, 2019
- Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapyRespiratory Medicine, 2019
- Acute progression of aspergillosis in a patient with lung cancer receiving nivolumabRespirology Case Reports, 2017
- Pembrolizumab reactivates pulmonary granulomatosisRespiratory Medicine Case Reports, 2017
- An Unusual Case of Aspergillus Fibrosing MediastinitisThe Annals of Thoracic Surgery, 2009
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2008